VANGUARD GROUP INC - LOXO ONCOLOGY INC ownership

LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 73 filers reported holding LOXO ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of LOXO ONCOLOGY INC
ValueSharesWeighting
Q4 2018$390,793,000
-14.3%
2,789,978
+4.5%
0.02%0.0%
Q3 2018$456,119,000
+10.1%
2,670,023
+11.8%
0.02%
+5.9%
Q2 2018$414,337,000
+69.9%
2,388,388
+13.0%
0.02%
+54.5%
Q1 2018$243,911,000
+46.9%
2,114,163
+7.2%
0.01%
+57.1%
Q4 2017$166,079,000
+26.6%
1,972,919
+38.6%
0.01%
+16.7%
Q3 2017$131,157,000
+78.8%
1,423,761
+55.7%
0.01%
+50.0%
Q2 2017$73,351,000
+137.7%
914,719
+24.7%
0.00%
+100.0%
Q1 2017$30,856,000
+87.1%
733,248
+42.8%
0.00%
+100.0%
Q4 2016$16,488,000
+24.7%
513,411
+1.6%
0.00%0.0%
Q3 2016$13,225,000
+14.3%
505,141
+1.2%
0.00%0.0%
Q2 2016$11,573,000
+52.6%
499,283
+80.0%
0.00%
Q1 2016$7,583,000
+5.5%
277,382
+9.8%
0.00%
Q4 2015$7,186,000
+161.6%
252,585
+60.7%
0.00%
Q3 2015$2,747,000
-14.2%
157,159
-11.4%
0.00%
Q2 2015$3,200,000
+479.7%
177,478
+300.1%
0.00%
Q1 2015$552,000
+31.4%
44,357
+24.2%
0.00%
Q4 2014$420,00035,7070.00%
Other shareholders
LOXO ONCOLOGY INC shareholders Q2 2016
NameSharesValueWeighting ↓
Aisling Capital LLC 4,028,920$129,409,00030.09%
Casdin Capital, LLC 360,000$11,561,0009.55%
DAFNA Capital Management LLC 139,722$4,487,0003.94%
Opaleye Management Inc. 125,000$4,014,0002.36%
Eventide Asset Management 740,000$23,765,0001.55%
Crawford Lake Capital Management, LLC 52,713$1,693,0001.22%
AWM Investment Company, Inc. 180,000$5,781,0001.13%
Orbimed Advisors 1,728,000$55,495,0000.71%
DRIEHAUS CAPITAL MANAGEMENT LLC 423,276$13,594,0000.48%
EAM Investors, LLC 111,268$3,573,0000.48%
View complete list of LOXO ONCOLOGY INC shareholders